---
figid: PMC3046044__nihms267952f1
figlink: /pmc/articles/PMC3046044/figure/F1/
number: F1
caption: 'Overview of the molecular mechanisms involved in nasopharyngeal carcinoma
  (NPC) development. NPC development begins with the upregulation of pathways that
  promote cellular proliferation: Akt pathway, mitogen-activated protein kinases (JNK,
  ERK), Wnt pathway, and EGFR signaling. Subsequent increases of transcription factors
  such as NF-κB and β-catenin lead to cellular proliferation via cell cycle dysregulation
  (high c-myc, cyclin D1, and cyclin E expression) and inhibition of tumor suppressors
  (p16, p27, and wild-type p53). In addition, cell adhesion abilities are compromised
  because of low E-cadherin levels and high expression of MMPs. Also, antiapoptotic
  mechanisms such as bcl-2, survivin, and telomerase are upregulated., Stimulatory
  effect; , inhibitory effect; orange color indicates apoptosis regulators; light
  blue color indicates cell adhesion proteins; yellow color indicates cell cycle regulators;
  dark blue color indicates proliferative pathways; green color indicates transcription
  factors; purple color indicates tumor suppressors; EGFR, epidermal growth factor
  receptor; ERK, extracellular signal related kinase; JNK, c-Jun N-terminal kinase;
  LMP1, latent membrane protein 1; MMP, matrix metalloproteinase; NPC, nasopharyngeal
  carcinoma; PTEN, phosphatase and tensin homolog; PI3K, phosphoinositol-3-kinase;
  RASSF, Ras association domain family; WIF, Wnt inhibitory factor; WT p53, wild-type
  p53. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]'
pmcid: PMC3046044
papertitle: NASOPHARYNGEAL CARCINOMA—REVIEW OF THE MOLECULAR MECHANISMS OF TUMORIGENESIS.
reftext: Josephine Chou, et al. Head Neck. ;30(7):946-963.
pmc_ranked_result_index: '87283'
pathway_score: 0.9490423
filename: nihms267952f1.jpg
figtitle: Molecular mechanisms involved in nasopharyngeal carcinoma (NPC) development
year: ''
organisms:
- Mus musculus
- Human gammaherpesvirus 4
- Catopsilia pomona
- Nicotiana tabacum
- Homo sapiens
ndex: adbd87fa-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3046044__nihms267952f1.html
  '@type': Dataset
  description: 'Overview of the molecular mechanisms involved in nasopharyngeal carcinoma
    (NPC) development. NPC development begins with the upregulation of pathways that
    promote cellular proliferation: Akt pathway, mitogen-activated protein kinases
    (JNK, ERK), Wnt pathway, and EGFR signaling. Subsequent increases of transcription
    factors such as NF-κB and β-catenin lead to cellular proliferation via cell cycle
    dysregulation (high c-myc, cyclin D1, and cyclin E expression) and inhibition
    of tumor suppressors (p16, p27, and wild-type p53). In addition, cell adhesion
    abilities are compromised because of low E-cadherin levels and high expression
    of MMPs. Also, antiapoptotic mechanisms such as bcl-2, survivin, and telomerase
    are upregulated., Stimulatory effect; , inhibitory effect; orange color indicates
    apoptosis regulators; light blue color indicates cell adhesion proteins; yellow
    color indicates cell cycle regulators; dark blue color indicates proliferative
    pathways; green color indicates transcription factors; purple color indicates
    tumor suppressors; EGFR, epidermal growth factor receptor; ERK, extracellular
    signal related kinase; JNK, c-Jun N-terminal kinase; LMP1, latent membrane protein
    1; MMP, matrix metalloproteinase; NPC, nasopharyngeal carcinoma; PTEN, phosphatase
    and tensin homolog; PI3K, phosphoinositol-3-kinase; RASSF, Ras association domain
    family; WIF, Wnt inhibitory factor; WT p53, wild-type p53. [Color figure can be
    viewed in the online issue, which is available at www.interscience.wiley.com.]'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BIRC5
  - TP53
  - AKT1
  - FGFR3
  - UNK
  - PTEN
  - CCNE1
  - MAPK3
  - CCNE2
  - CDH1
  - MAPK1
  - CDKN2A
  - FGFR1
  - FGFRL1
  - NFKB1
  - FGFR4
  - AKT3
  - SERPINF2
  - MYC
  - FGFR2
  - AKT2
  - Cancer
genes:
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: UNK
  symbol: UNK
  source: hgnc_symbol
  hgnc_symbol: UNK
  entrez: '85451'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AP-I
  symbol: API
  source: hgnc_alias_symbol
  hgnc_symbol: SERPINF2
  entrez: '5345'
- word: C-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3046044__F1
redirect_from: /figures/PMC3046044__F1
figtype: Figure
---
